Search - tctmd.com

Displaying 1 - 20 of 200

Sort: Relevancy | Date

Presentation TCT 2025

Linking Clinical Presentation with Morphology: Understanding Plaque Characteristics

Presenter: Akiko Maehara

October 27, 2025

Presentation TCT 2025

TCT 654: Functional Classification based on the Quantitative Flow Ratio and Long-term Clinical Outcomes in Three-Vessel Disease: the CREDO-Kyoto Registry Cohort-3 QFR Study

Presenter: Akinori Tamura

October 26, 2025

Presentation TCT 2025

New Imaging Technologies to Guide Coronary PCI

Presenter: Akiko Maehara

October 26, 2025

Presentation TCT 2025

Protocol-Driven Success: Reducing AKI Through Standardized Contrast Management

Presenter: Kirk N. Garratt

October 26, 2025

Presentation TCT 2025

Contrast-Induced AKI: Quantifying the Risk, Reducing the Harm

Presenter: Roxana Mehran

October 26, 2025

Presentation TCT 2025

TCT 186: Management of In-Stent Restenosis in Coronary Vein Grafts: Revascularization Strategies and Outcomes

Presenter: Oludamilola Akinmolayemi

October 26, 2025

Presentation TCT 2025

TCT 2: Win Ratio Analysis of 1-Year Outcomes in the LANDMARK Trial: Myval vs Contemporary THVs (Sapien or Evolut) in Patients with Symptomatic Severe Aortic Stenosis

Presenter: Akihiro Tobe

October 25, 2025

Presentation TCT 2024

Editorial Comments

Presenter: Akiko Maehara

October 30, 2024

Presentation TCT 2024

AI In Intravascular Imaging and Physiology in the Modern Cath Lab

Presenter: Akiko Maehara

October 30, 2024

Presentation TCT 2024

TCT 331: Use of Automated Contrast Injector Versus Manifold in Cardiac Catheterization Laboratory Procedures Is Not Associated With Reduced Procedural Contrast Volumes or Rates of Acute Kidney Injury

Presenter: Ahmed Athar

October 30, 2024

Presentation TCT 2024

TCT 333: Contrast Utilization During Bifurcation Percutaneous Coronary Intervention

Presenter: Athanasios Rempakos

October 30, 2024

Presentation TCT 2024

TCT 332: Clinical and Financial Impact of an Automated vs. Manual Personal Contrast Calculator Tool to Prevent Contrast Nephropathy After Percutaneous Coronary Intervention

Presenter: Alan Zajarias

October 30, 2024

Presentation TCT 2024

TCT 334: Long-Term Prognosis After Acute Coronary Syndrome Due to De Novo Coronary Artery Lesions and Stent Thrombosis in Patients With and Without Hemodialysis

Presenter: Takayuki Ishihara

October 30, 2024

Presentation TCT 2024

TCT 335: Contrast Associated Acute Kidney Injury Following Intraarterial vs Intravenous Contrast Administration: A Meta-Analysis

Presenter: Muhammad Sabih Saleem

October 30, 2024

Presentation TCT 2024

TCT 328: Race, Percutaneous Coronary Interventions Outcomes for ST-Elevated Myocardial Infarction, and Chronic Kidney Disease: A Propensity Matched National Database Study

Presenter: Salman Abdul Basit

October 30, 2024

Presentation TCT 2024

TCT 327: Efficacy of High-Dose Statins on the Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization: Updated Systematic Review and Meta-Analysis

Presenter: Montaser Elkholy

October 30, 2024

Presentation TCT 2024

TCT 330: Outcomes of Percutaneous Coronary Intervention in Patients With Autosomal Dominant Polycystic Kidney Disease: National Inpatient Sample 2016-2021

Presenter: Daniel Hanna

October 30, 2024

Presentation TCT 2024

TCT 325: Safety and Efficacy of Ultra-Low or Zero-Contrast IVUS-Guided Percutaneous Coronary Intervention in Advance Chronic Kidney Disease Patients

Presenter: Eunice Chuah

October 30, 2024

Presentation TCT 2024

TCT 326: Outcomes of Acute Kidney Injury and Hemodialysis Use in Acute Pulmonary Embolism

Presenter: Aryan Mehta

October 30, 2024

Presentation TCT 2024

TCT 329: Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function

Presenter: Sem Rikken

October 30, 2024

Advertisement

Linking Clinical Presentation with Morphology: Understanding Plaque Characteristics

TCT 654: Functional Classification based on the Quantitative Flow Ratio and Long-term Clinical Outcomes in Three-Vessel Disease: the CREDO-Kyoto Registry Cohort-3 QFR Study

New Imaging Technologies to Guide Coronary PCI

Protocol-Driven Success: Reducing AKI Through Standardized Contrast Management

Contrast-Induced AKI: Quantifying the Risk, Reducing the Harm

TCT 186: Management of In-Stent Restenosis in Coronary Vein Grafts: Revascularization Strategies and Outcomes

TCT 2: Win Ratio Analysis of 1-Year Outcomes in the LANDMARK Trial: Myval vs Contemporary THVs (Sapien or Evolut) in Patients with Symptomatic Severe Aortic Stenosis

Editorial Comments

AI In Intravascular Imaging and Physiology in the Modern Cath Lab

TCT 331: Use of Automated Contrast Injector Versus Manifold in Cardiac Catheterization Laboratory Procedures Is Not Associated With Reduced Procedural Contrast Volumes or Rates of Acute Kidney Injury

TCT 333: Contrast Utilization During Bifurcation Percutaneous Coronary Intervention

TCT 332: Clinical and Financial Impact of an Automated vs. Manual Personal Contrast Calculator Tool to Prevent Contrast Nephropathy After Percutaneous Coronary Intervention

TCT 334: Long-Term Prognosis After Acute Coronary Syndrome Due to De Novo Coronary Artery Lesions and Stent Thrombosis in Patients With and Without Hemodialysis

TCT 335: Contrast Associated Acute Kidney Injury Following Intraarterial vs Intravenous Contrast Administration: A Meta-Analysis

TCT 328: Race, Percutaneous Coronary Interventions Outcomes for ST-Elevated Myocardial Infarction, and Chronic Kidney Disease: A Propensity Matched National Database Study

TCT 327: Efficacy of High-Dose Statins on the Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization: Updated Systematic Review and Meta-Analysis

TCT 330: Outcomes of Percutaneous Coronary Intervention in Patients With Autosomal Dominant Polycystic Kidney Disease: National Inpatient Sample 2016-2021

TCT 325: Safety and Efficacy of Ultra-Low or Zero-Contrast IVUS-Guided Percutaneous Coronary Intervention in Advance Chronic Kidney Disease Patients

TCT 326: Outcomes of Acute Kidney Injury and Hemodialysis Use in Acute Pulmonary Embolism

TCT 329: Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content